Newsfeeds - Spark Newswire

1 minute read

Acer Therapeutics Announces Promotion of Tanya Hayden To Chief Operating Officer

Today, 11:19 PM

NEWTON, Mass., June 21, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and

ACER

1 minute read

Acer Therapeutics Says Has Not Yet Received Decision From FDA On 505(b)(2) New Drug Application For ACER-001

By Bill Haddad

Today, 11:19 PM

Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical

ACER

6 minute read

95 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:19 PM

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.

ACER

3 minute read

52 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 11:19 PM

Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.

ACER

3 minute read

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More

By Shanthi Rexaline

Today, 11:19 PM

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

ACER

5 minute read

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

By Shanthi Rexaline

Today, 11:19 PM

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month, bringing the total for the year to 15. This compares to the 24 NMEs the Food and Drug Administration approved by May 2021.

ACAD

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 11:19 PM

Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.

ACER

1 minute read

Acer Therapeutics Files Prospectus Related To Offer And Resale From Time To Time By The Selling Stockholders Of Up To 2.5M Shares Of Common Stock

By Benzinga Newsdesk

Today, 11:19 PM

-SEC Filing

ACER

1 minute read

Acer Therapeutics Reports Enrollment Of First Patient In Its Phase 2a Trial Of ACER-801 For Treatment Of Moderate To Severe Vasomotor Symptoms Associated With Menopause

By Benzinga Newsdesk

Today, 11:19 PM

ACER

1 minute read

Acer Therapeutics Q4 EPS $(0.31) Up From $(0.50) YoY

By Benzinga Newsdesk

Today, 11:19 PM

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.31) per share. This is a 38 percent increase over losses of $(0.50) per share from the same period last year.

ACER